Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Health services symbols : Optn save search
Optinose to Present at the Needham Virtual Healthcare Conference
Published: 2024-04-04 (Crawled : 20:00) - globenewswire.com
OPTN | $0.9261 -0.17% 490K
|
Health Services
|
| O: 1.46%
H: 0.72%
C: -5.04%
conference
XHANCE Approved by FDA as First and Only Medication Indicated for Treatment of Adults with Chronic Rhinosinusitis without Nasal Polyps
Published: 2024-03-15 (Crawled : 20:00) - globenewswire.com
OPTN | $0.9261 -0.17% 490K
|
Health Services
| Email alert
Add to watchlist
fda first xhance approved treatment
Optinose Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Operational Highlights
Published: 2024-03-07 (Crawled : 12:00) - globenewswire.com
OPTN | $0.9261 -0.17% 490K
|
Health Services
|
| O: -4.0%
H: 5.95%
C: 2.38%
year financial
Optinose Announces Reporting Date for Fourth Quarter 2023 Financial Results
Published: 2024-02-29 (Crawled : 22:00) - globenewswire.com
OPTN | $0.9261 -0.17% 490K
|
Health Services
|
| O: -0.56%
H: 7.91%
C: 7.91%
financial results
Optinose Announces the Publication of ReOpen Phase 3 Clinical Trial Program Evaluating XHANCE in the Journal of Allergy and Clinical Immunology: In Practice
Published: 2024-01-18 (Crawled : 17:00) - globenewswire.com
OPTN | $0.9261 -0.17% 490K
|
Health Services
|
| O: -0.77%
H: 4.63%
C: 1.55%
xhance publication program trial
Optinose Announces 3-Month Extension of FDA Review Period for the Supplemental New Drug Application for XHANCE
Published: 2023-12-06 (Crawled : 12:00) - globenewswire.com
OPTN | $0.9261 -0.17% 490K
|
Health Services
|
| O: -17.01%
H: 1.64%
C: 0.82%
fda xhance drug review extension application
Optinose to Present at the 35th Annual Piper Sandler Healthcare Conference
Published: 2023-11-22 (Crawled : 14:00) - globenewswire.com
OPTN | $0.9261 -0.17% 490K
|
Health Services
|
| O: 0.0%
H: 2.46%
C: 0.41%
conference
Optinose Reports Third Quarter 2023 Financial Results and Operational Updates
Published: 2023-11-09 (Crawled : 12:00) - globenewswire.com
OPTN | $0.9261 -0.17% 490K
|
Health Services
|
| O: 11.29%
H: 0.0%
C: -11.59%
financial results
Optinose Announces Reporting Date for Third Quarter 2023 Financial Results
Published: 2023-10-27 (Crawled : 12:00) - globenewswire.com
OPTN | $0.9261 -0.17% 490K
|
Health Services
|
| O: 0.0%
H: 3.36%
C: 2.52%
financial results
Optinose to Present at the 2023 Cantor Global Healthcare Conference
Published: 2023-09-22 (Crawled : 13:00) - globenewswire.com
OPTN | $0.9261 -0.17% 490K
|
Health Services
|
| O: 0.81%
H: 4.0%
C: 0.8%
conference global
Optinose Reports Second Quarter 2023 Financial Results and Operational Updates
Published: 2023-08-10 (Crawled : 11:00) - globenewswire.com
OPTN | $0.9261 -0.17% 490K
|
Health Services
|
| O: 10.34%
H: 0.0%
C: -3.13%
financial results
Optinose Announces Preliminary Second Quarter 2023 XHANCE Net Revenue of $19.5 Million
Published: 2023-07-27 (Crawled : 11:00) - globenewswire.com
OPTN | $0.9261 -0.17% 490K
|
Health Services
|
| O: 2.75%
H: 6.25%
C: -1.79%
xhance
Optinose Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Published: 2023-06-16 (Crawled : 20:00) - globenewswire.com
OPTN | $0.9261 -0.17% 490K
|
Health Services
| Email alert
Add to watchlist
nasdaq grant
Optinose to Present at the Jefferies Healthcare Conference
Published: 2023-06-02 (Crawled : 17:00) - globenewswire.com
OPTN | $0.9261 -0.17% 490K
|
Health Services
|
| O: -2.4%
H: 2.46%
C: -0.82%
conference
Optinose Reports First Quarter 2023 Financial Results and Operational Updates
Published: 2023-05-11 (Crawled : 11:00) - globenewswire.com
OPTN | $0.9261 -0.17% 490K
|
Health Services
|
| O: -5.38%
H: 15.34%
C: 12.5%
financial results
Optinose Announces FDA Acceptance of Supplemental New Drug Application for XHANCE
Published: 2023-05-04 (Crawled : 11:00) - globenewswire.com
OPTN | $0.9261 -0.17% 490K
|
Health Services
|
| O: 0.0%
H: 12.57%
C: 11.43%
fda xhance drug application
Optinose Announces Reporting Date for First Quarter 2023 Financial Results
Published: 2023-05-01 (Crawled : 21:00) - globenewswire.com
OPTN | $0.9261 -0.17% 490K
|
Health Services
|
| O: 1.12%
H: 1.11%
C: -3.89%
financial results
GRI Bio (NASDAQ: GRI) Announces Appointment of Leanne Kelly as Chief Financial Officer
Published: 2023-04-25 (Crawled : 13:00) - globenewswire.com
OPTN | $0.9261 -0.17% 490K
|
Health Services
|
| O: -1.1%
H: 1.68%
C: -1.12%
kelly financial
Optinose Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2023-04-18 (Crawled : 10:00) - globenewswire.com
OPTN | $0.9261 -0.17% 490K
|
Health Services
|
| O: 0.49%
H: 0.49%
C: -1.46%
nasdaq grants
Optinose to Present at the Needham Virtual Healthcare Conference
Published: 2023-04-12 (Crawled : 04:00) - globenewswire.com
OPTN | $0.9261 -0.17% 490K
|
Health Services
|
| O: 0.51%
H: 2.83%
C: -1.02%
conference
Gainers vs Losers
| 71% | 29% |
Top 10 Gainers
AGBA | News | $1.27 217.5% 120M
|
Finance
EGOX | $0.0503 39.72% 320M
|
RWOD | $10.52 31.56% 5.9M
|
n/a
ZCMD | $1.905 31.38% 30M
|
Commercial Services
MRDB 4 | $0.536 27.65% 2M
|
n/a
BSFC | $0.0822 27.64% 75M
|
Manufacturing
TPET | $0.4121 25.68% 45M
|
n/a
NVFY | $2.65 25.59% 33M
|
Consumer Durables
INDO | $5.1 25.0% 15M
|
Energy Minerals
CHRO | $1.53 24.9% 100K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.